Omar A. T.
- Country
- France
- Department
- Rhumatologie
Research Overview
- Comparison of Bimekizumab versus Adalimumab for the Treatment of Anterior Chest Wall Pain in Patients with Active Axial Spondyloarthritis Refractory to NSAIDs
- Evaluation of Baricitinib Combined with Anti-TNF Agents Adalimumab or Etanercept Versus Baricitinib Monotherapy in Refractory Rheumatoid Arthritis Patients
Data & Insights
Has run more than one trial at 14 of 41 partner sites.
Specializations
Rheumatoid Arthritis Management
This investigator specializes in advancing treatment approaches for rheumatoid arthritis, with particular focus on combination therapy strategies.
- Advanced therapeutic combinations
- Refractory RA management
- Long-term disease control
Their research explores innovative treatment pathways in autoimmune arthritis management, particularly examining the effectiveness of combining different therapeutic agents.
Immunology Research
The investigator focuses on understanding immunological mechanisms in arthritis treatment, specifically studying the interaction between different therapeutic pathways.
- Immune system modulation
- Inflammatory response control
- Targeted therapy approaches
Their work involves evaluating immune response patterns in patients with chronic inflammatory conditions.
Treatment Innovation
The investigator's work centers on developing enhanced therapeutic strategies for treatment-resistant arthritis.
- Novel treatment combinations
- Clinical efficacy assessment
- Treatment optimization
Their research aims to advance understanding of therapeutic synergies in managing complex autoimmune conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.